|
Having trouble viewing this email? View it as a Web page.
You are subscribed to one of CDC's code sets email subscription service. This email serves to inform you that information has recently been updated and is now available.
The CVX table was updated to reflect the fact that Comvax is no longer being manufactured. It is set to inactive status, but existing stock will continue to be reported until gone or expired.
The Product Name table was updated to show that GlaxoSmithKline has purchased Rabavert, Menveo and Bexsero vaccines from Novartis. The packaging will transition over the next quarter. At that time the relationship to Novartis will be changed to inactive. New NDC codes are anticipated, but are not published at this time. Mapping product names to CVX and MVX
|
